Live news related to VIVORYON stock (NL00150002Q7): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
German biotech company Vivoryon has reduced its annual deficit by 57% to 8.9 million euros in 2025 due to a substantial decrease in research and devel…
Vivoryon Therapeutics N.V., a clinical-stage biotechnology company, announces its management's participation in an investor conference scheduled for A…
Vivoryon Therapeutics presented new data analyses at the World Congress of Nephrology, reinforcing the scientific validation of its therapeutic approa…
